{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:44:53Z","timestamp":1786981493817,"version":"build-2736575974"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran","award":["65139"],"award-info":[{"award-number":["65139"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s11033-022-08033-5","type":"journal-article","created":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T03:04:45Z","timestamp":1667963085000},"page":"553-563","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["MicroRNA-155 acts as a potential prognostic and diagnostic factor in patients with ankylosing spondylitis by modulating SOCS3"],"prefix":"10.1007","volume":"50","author":[{"given":"Mohammadsaleh","family":"Jahangir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Saeed","family":"Kahrizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Natami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raziyeh","family":"Moaref Pour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadi","family":"Ghoreishizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Hemmatzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4679-9658","authenticated-orcid":false,"given":"Navid","family":"Shomali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siamak","family":"Sandoghchian Shotorbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,9]]},"reference":[{"key":"8033_CR1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key001","author":"D Simone","year":"2018","unstructured":"Simone D, Al Mossawi MH, Bowness P (2018) Progress in our understanding of the pathogenesis of ankylosing spondylitis. Rheumatology (Oxford). https:\/\/doi.org\/10.1093\/rheumatology\/key001","journal-title":"Rheumatology (Oxford)"},{"key":"8033_CR2","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/imm.13242","volume":"161","author":"A Voruganti","year":"2020","unstructured":"Voruganti A, Bowness P (2020) New developments in our understanding of ankylosing spondylitis pathogenesis. Immunology 161:94\u2013102","journal-title":"Immunology"},{"key":"8033_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev-immunol-032414-112110","volume":"33","author":"P Bowness","year":"2015","unstructured":"Bowness P (2015) HLA-B27. Annu Rev Immunol 33:29\u201348","journal-title":"Annu Rev Immunol"},{"key":"8033_CR4","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3349\/ymj.2010.51.4.484","volume":"51","author":"ES Hwang","year":"2010","unstructured":"Hwang ES (2010) Transcriptional regulation of T helper 17 cell differentiation. Yonsei Med J 51:484\u2013491","journal-title":"Yonsei Med J"},{"key":"8033_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/cells8080818","author":"D Tateiwa","year":"2019","unstructured":"Tateiwa D, Yoshikawa H, Kaito T (2019) Cartilage and bone destruction in arthritis: pathogenesis and treatment strategy: a literature review. Cells. https:\/\/doi.org\/10.3390\/cells8080818","journal-title":"Cells"},{"key":"8033_CR6","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1002\/iub.2345","volume":"72","author":"SA Nabipoorashrafi","year":"2020","unstructured":"Nabipoorashrafi SA, Shomali N, Sadat-Hatamnezhad L et al (2020) MiR-143 acts as an inhibitor of migration and proliferation as well as an inducer of apoptosis in melanoma cancer cells in vitro. IUBMB Life 72:2034\u20132044","journal-title":"IUBMB Life"},{"key":"8033_CR7","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s12029-019-00356-0","volume":"52","author":"R Tamjidifar","year":"2021","unstructured":"Tamjidifar R, Akbari M, Tarzi S et al (2021) Prognostic and diagnostic values of miR-506 and SPON 1 in colorectal cancer with clinicopathological considerations. J Gastrointest Cancer 52:125\u2013129","journal-title":"J Gastrointest Cancer"},{"key":"8033_CR8","doi-asserted-by":"publisher","first-page":"107355","DOI":"10.1016\/j.intimp.2020.107355","volume":"92","author":"M Azar","year":"2021","unstructured":"Azar M, Aghazadeh H, Mohammed HN et al (2021) miR-193a-5p as a promising therapeutic candidate in colorectal cancer by reducing 5-FU and oxaliplatin chemoresistance by targeting CXCR4. Int Immunopharmacol 92:107355","journal-title":"Int Immunopharmacol"},{"key":"8033_CR9","doi-asserted-by":"publisher","first-page":"577347","DOI":"10.1016\/j.jneuroim.2020.577347","volume":"347","author":"S Ghaderian","year":"2020","unstructured":"Ghaderian S, Shomali N, Behravesh S et al (2020) The emerging role of lncRNAs in multiple sclerosis. J Neuroimmunol 347:577347","journal-title":"J Neuroimmunol"},{"key":"8033_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2174\/18755666MTA2pNTIk0","volume":"21","author":"N Shomali","year":"2021","unstructured":"Shomali N, Hatamnezhad LS, Tarzi S et al (2021) Heat shock proteins regulating toll-like receptors and the immune system could be a novel therapeutic target for melanoma. Curr Mol Med 21:15\u201324","journal-title":"Curr Mol Med"},{"key":"8033_CR11","doi-asserted-by":"publisher","first-page":"839945","DOI":"10.3389\/fimmu.2022.839945","volume":"13","author":"N Shomali","year":"2022","unstructured":"Shomali N, Suliman Maashi M, Baradaran B et al (2022) Dysregulation of survivin-targeting microRNAs in autoimmune diseases: new perspectives for novel therapies. Front Immunol 13:839945","journal-title":"Front Immunol"},{"key":"8033_CR12","doi-asserted-by":"publisher","first-page":"669382","DOI":"10.3389\/fimmu.2021.669382","volume":"12","author":"S Pashangzadeh","year":"2021","unstructured":"Pashangzadeh S, Motallebnezhad M, Vafashoar F et al (2021) Implications the role of miR-155 in the pathogenesis of autoimmune diseases. Front Immunol 12:669382","journal-title":"Front Immunol"},{"key":"8033_CR13","first-page":"7042","volume":"23","author":"ZQ Liu","year":"2019","unstructured":"Liu ZQ, Feng J, Shi LL et al (2019) Influences of miR-155\/NF-\u03baB signaling pathway on inflammatory factors in ARDS in neonatal pigs. Eur Rev Med Pharmacol Sci 23:7042\u20137048","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"8033_CR14","doi-asserted-by":"publisher","first-page":"8874854","DOI":"10.1155\/2021\/8874854","volume":"2021","author":"M Chen","year":"2021","unstructured":"Chen M, Wang F, Xia H et al (2021) MicroRNA-155: regulation of immune cells in sepsis. Mediators Inflamm 2021:8874854","journal-title":"Mediators Inflamm"},{"key":"8033_CR15","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1097\/BRS.0000000000001339","volume":"41","author":"BP Qian","year":"2016","unstructured":"Qian BP, Ji ML, Qiu Y et al (2016) Identification of serum miR-146a and miR-155 as novel noninvasive complementary biomarkers for ankylosing spondylitis. Spine 41:735\u2013742","journal-title":"Spine"},{"key":"8033_CR16","doi-asserted-by":"publisher","DOI":"10.21608\/resoncol.2022.114548.1159","author":"R Chakraborty","year":"2022","unstructured":"Chakraborty R, Darido C, Alnakli AA et al (2022) A review on the dual role of SOCS3 in cancer. Res Oncol. https:\/\/doi.org\/10.21608\/resoncol.2022.114548.1159","journal-title":"Res Oncol"},{"key":"8033_CR17","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.humimm.2015.09.037","volume":"76","author":"Y Yin","year":"2015","unstructured":"Yin Y, Liu W, Dai Y (2015) SOCS3 and its role in associated diseases. Hum Immunol 76:775\u2013780","journal-title":"Hum Immunol"},{"key":"8033_CR18","doi-asserted-by":"publisher","first-page":"e0116067","DOI":"10.1371\/journal.pone.0116067","volume":"10","author":"L Bao","year":"2015","unstructured":"Bao L, Fu X, Si M et al (2015) MicroRNA-185 targets SOCS3 to inhibit beta-cell dysfunction in diabetes. PLoS ONE 10:e0116067","journal-title":"PLoS ONE"},{"key":"8033_CR19","doi-asserted-by":"publisher","first-page":"e334","DOI":"10.1038\/cddis.2012.69","volume":"3","author":"S Madonna","year":"2012","unstructured":"Madonna S, Scarponi C, Pallotta S et al (2012) Anti-apoptotic effects of suppressor of cytokine signaling 3 and 1 in psoriasis. Cell Death Dis 3:e334","journal-title":"Cell Death Dis"},{"key":"8033_CR20","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/sji.12475","volume":"84","author":"B Sukka-Ganesh","year":"2016","unstructured":"Sukka-Ganesh B, Larkin J 3rd (2016) Therapeutic potential for targeting the suppressor of cytokine signalling-1 pathway for the treatment of SLE. Scand J Immunol 84:299\u2013309","journal-title":"Scand J Immunol"},{"key":"8033_CR21","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3389\/fimmu.2014.00058","volume":"5","author":"B Carow","year":"2014","unstructured":"Carow B, Rottenberg ME (2014) SOCS3, a major regulator of infection and inflammation. Front Immunol 5:58","journal-title":"Front Immunol"},{"key":"8033_CR22","doi-asserted-by":"publisher","first-page":"e12727","DOI":"10.1111\/sji.12727","volume":"88","author":"Y Gao","year":"2018","unstructured":"Gao Y, Zhao H, Wang P et al (2018) The roles of SOCS3 and STAT3 in bacterial infection and inflammatory diseases. Scand J Immunol 88:e12727","journal-title":"Scand J Immunol"},{"key":"8033_CR23","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jaut.2014.01.015","volume":"48","author":"SP Raychaudhuri","year":"2014","unstructured":"Raychaudhuri SP, Deodhar A (2014) The classification and diagnostic criteria of ankylosing spondylitis. J Autoimmun 48:128\u2013133","journal-title":"J Autoimmun"},{"key":"8033_CR24","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/imm.12468","volume":"145","author":"R Mashima","year":"2015","unstructured":"Mashima R (2015) Physiological roles of miR-155. Immunology 145:323\u2013333","journal-title":"Immunology"},{"key":"8033_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fimmu.2015.00019","volume":"6","author":"FJ Sheedy","year":"2015","unstructured":"Sheedy FJ (2015) Turning 21: induction of miR-21 as a key switch in the inflammatory response. Front Immunol 6:19","journal-title":"Front Immunol"},{"key":"8033_CR26","first-page":"575","volume":"17","author":"Y Tao","year":"2019","unstructured":"Tao Y, Ai R, Hao Y et al (2019) Role of miR-155 in immune regulation and its relevance in oral lichen planus. Exp Ther Med 17:575\u2013586","journal-title":"Exp Ther Med"},{"key":"8033_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21041319","author":"V Scalavino","year":"2020","unstructured":"Scalavino V, Liso M, Serino G (2020) Role of microRNAs in the regulation of dendritic cell generation and function. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21041319","journal-title":"Int J Mol Sci"},{"key":"8033_CR28","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.3389\/fimmu.2017.01932","volume":"8","author":"S Alivernini","year":"2017","unstructured":"Alivernini S, Gremese E, McSharry C et al (2017) MicroRNA-155-at the critical interface of innate and adaptive immunity in arthritis. Front Immunol 8:1932","journal-title":"Front Immunol"},{"key":"8033_CR29","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.immuni.2014.09.015","volume":"41","author":"R Hu","year":"2014","unstructured":"Hu R, Kagele DA, Huffaker TB et al (2014) miR-155 promotes T follicular helper cell accumulation during chronic, low-grade inflammation. Immunity 41:605\u2013619","journal-title":"Immunity"},{"key":"8033_CR30","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.immuni.2014.03.014","volume":"40","author":"TM Escobar","year":"2014","unstructured":"Escobar TM, Kanellopoulou C, Kugler DG et al (2014) miR-155 activates cytokine gene expression in Th17 cells by regulating the DNA-binding protein Jarid2 to relieve polycomb-mediated repression. Immunity 40:865\u2013879","journal-title":"Immunity"},{"key":"8033_CR31","doi-asserted-by":"publisher","first-page":"e46082","DOI":"10.1371\/journal.pone.0046082","volume":"7","author":"R Yao","year":"2012","unstructured":"Yao R, Ma YL, Liang W et al (2012) MicroRNA-155 modulates Treg and Th17 cells differentiation and Th17 cell function by targeting SOCS1. PLoS ONE 7:e46082","journal-title":"PLoS ONE"},{"key":"8033_CR32","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.4049\/jimmunol.1003952","volume":"187","author":"G Murugaiyan","year":"2011","unstructured":"Murugaiyan G, Beynon V, Mittal A et al (2011) Silencing microRNA-155 ameliorates experimental autoimmune encephalomyelitis. J Immunol 187:2213\u20132221","journal-title":"J Immunol"},{"key":"8033_CR33","doi-asserted-by":"publisher","first-page":"41328","DOI":"10.1074\/jbc.M110.146852","volume":"285","author":"F Louafi","year":"2010","unstructured":"Louafi F, Martinez-Nunez RT, Sanchez-Elsner T (2010) MicroRNA-155 targets SMAD2 and modulates the response of macrophages to transforming growth factor-{beta}. J Biol Chem 285:41328\u201341336","journal-title":"J Biol Chem"},{"key":"8033_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094332","author":"K Maciak","year":"2021","unstructured":"Maciak K, Dziedzic A, Miller E et al (2021) miR-155 as an important regulator of multiple sclerosis pathogenesis. a review. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22094332","journal-title":"Int J Mol Sci"},{"key":"8033_CR35","first-page":"3716","volume":"97","author":"YL Ye","year":"2017","unstructured":"Ye YL, Pang Z, Gu W et al (2017) Expression of microRNA-155 in inflammatory bowel disease and its clinical significance. Zhonghua Yi Xue Za Zhi 97:3716\u20133719","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"8033_CR36","first-page":"217","volume":"43","author":"R Shumnalieva","year":"2018","unstructured":"Shumnalieva R, Kachakova D, Shoumnalieva-Ivanova V et al (2018) Whole peripheral blood miR-146a and miR-155 expression levels in systemic lupus erythematosus patients. Acta Reumatol Port 43:217\u2013225","journal-title":"Acta Reumatol Port"},{"key":"8033_CR37","doi-asserted-by":"publisher","first-page":"205873842093374","DOI":"10.1177\/2058738420933742","volume":"34","author":"M El-Komy","year":"2020","unstructured":"El-Komy M, Amin I, El-Hawary MS et al (2020) Upregulation of the miRNA-155, miRNA-210, and miRNA-20b in psoriasis patients and their relation to IL-17. Int J Immunopathol Pharmacol 34:2058738420933742","journal-title":"Int J Immunopathol Pharmacol"},{"key":"8033_CR38","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3389\/fimmu.2012.00020","volume":"3","author":"A Yoshimura","year":"2012","unstructured":"Yoshimura A, Suzuki M, Sakaguchi R et al (2012) SOCS, inflammation, and autoimmunity. Front Immunol 3:20","journal-title":"Front Immunol"},{"key":"8033_CR39","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1002\/eji.201344369","volume":"44","author":"Y Liang","year":"2014","unstructured":"Liang Y, Xu WD, Peng H et al (2014) SOCS signaling in autoimmune diseases: molecular mechanisms and therapeutic implications. Eur J Immunol 44:1265\u20131275","journal-title":"Eur J Immunol"},{"key":"8033_CR40","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.3389\/fimmu.2020.01336","volume":"11","author":"A Lamana","year":"2020","unstructured":"Lamana A, Villares R, Seoane IV et al (2020) Identification of a human SOCS1 polymorphism that predicts rheumatoid arthritis severity. Front Immunol 11:1336","journal-title":"Front Immunol"},{"key":"8033_CR41","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.jns.2017.02.015","volume":"375","author":"M Toghi","year":"2017","unstructured":"Toghi M, Taheri M, Arsang-Jang S et al (2017) SOCS gene family expression profile in the blood of multiple sclerosis patients. J Neurol Sci 375:481\u2013485","journal-title":"J Neurol Sci"},{"key":"8033_CR42","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.antiviral.2013.02.009","volume":"98","author":"A Zhai","year":"2013","unstructured":"Zhai A, Qian J, Kao W et al (2013) Borna disease virus encoded phosphoprotein inhibits host innate immunity by regulating miR-155. Antiviral Res 98:66\u201375","journal-title":"Antiviral Res"},{"key":"8033_CR43","doi-asserted-by":"publisher","first-page":"104109","DOI":"10.1016\/j.dci.2021.104109","volume":"122","author":"C Salazar","year":"2021","unstructured":"Salazar C, Galaz M, Ojeda N et al (2021) Expression of ssa-miR-155 during ISAV infection in vitro: putative role as a modulator of the immune response in salmo salar. Dev Comp Immunol 122:104109","journal-title":"Dev Comp Immunol"},{"key":"8033_CR44","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.3389\/fimmu.2019.01843","volume":"10","author":"S Liu","year":"2019","unstructured":"Liu S, Yan R, Chen B et al (2019) Influenza virus-induced robust expression of SOCS3 contributes to excessive production of IL-6. Front Immunol 10:1843","journal-title":"Front Immunol"},{"key":"8033_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.fsi.2021.01.005","volume":"111","author":"JS Kwak","year":"2021","unstructured":"Kwak JS, Kim KH (2021) Effect of miR-155 on type I interferon response in epithelioma papulosum cyprini cells. Fish Shellfish Immunol 111:1\u20135","journal-title":"Fish Shellfish Immunol"},{"key":"8033_CR46","doi-asserted-by":"publisher","first-page":"e322","DOI":"10.3324\/haematol.2018.202374","volume":"104","author":"F Todaro","year":"2019","unstructured":"Todaro F, Tamassia N, Pinelli M et al (2019) Multisystem autoimmune disease caused by increased STAT3 phosphorylation and dysregulated gene expression. Haematologica 104:e322\u2013e325","journal-title":"Haematologica"},{"key":"8033_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173107","volume":"878","author":"T Gharibi","year":"2020","unstructured":"Gharibi T, Babaloo Z, Hosseini A et al (2020) Targeting STAT3 in cancer and autoimmune diseases. Eur J Pharmacol 878:173107","journal-title":"Eur J Pharmacol"},{"key":"8033_CR48","doi-asserted-by":"publisher","first-page":"107024","DOI":"10.1016\/j.intimp.2020.107024","volume":"88","author":"M Esmaeil Amini","year":"2020","unstructured":"Esmaeil Amini M, Shomali N, Bakhshi A et al (2020) Gut microbiome and multiple sclerosis: new insights and perspective. Int Immunopharmacol 88:107024","journal-title":"Int Immunopharmacol"},{"key":"8033_CR49","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.3389\/fimmu.2019.01267","volume":"10","author":"\u00c1C Cevey","year":"2019","unstructured":"Cevey \u00c1C, Penas FN, Alba Soto CD et al (2019) IL-10\/STAT3\/SOCS3 axis is involved in the anti-inflammatory effect of benznidazole. Front Immunol 10:1267","journal-title":"Front Immunol"},{"key":"8033_CR50","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.imbio.2015.09.021","volume":"221","author":"T Gharibi","year":"2016","unstructured":"Gharibi T, Majidi J, Kazemi T et al (2016) Biological effects of IL-21 on different immune cells and its role in autoimmune diseases. Immunobiology 221:357\u2013367","journal-title":"Immunobiology"},{"key":"8033_CR51","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1002\/jcp.26158","volume":"233","author":"P Dinesh","year":"2018","unstructured":"Dinesh P, Rasool M (2018) Multifaceted role of IL-21 in rheumatoid arthritis: current understanding and future perspectives. J Cell Physiol 233:3918\u20133928","journal-title":"J Cell Physiol"},{"key":"8033_CR52","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/cmi.2014.58","volume":"12","author":"XM Deng","year":"2015","unstructured":"Deng XM, Yan SX, Wei W (2015) IL-21 acts as a promising therapeutic target in systemic lupus erythematosus by regulating plasma cell differentiation. Cell Mol Immunol 12:31\u201339","journal-title":"Cell Mol Immunol"},{"key":"8033_CR53","doi-asserted-by":"publisher","first-page":"5962624","DOI":"10.1155\/2018\/5962624","volume":"2018","author":"TL Holm","year":"2018","unstructured":"Holm TL, Tornehave D, S\u00f8ndergaard H et al (2018) Evaluating IL-21 as a potential therapeutic target in crohn\u2019s disease. Gastroenterol Res Pract 2018:5962624","journal-title":"Gastroenterol Res Pract"},{"key":"8033_CR54","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s00125-015-3509-8","volume":"58","author":"RC Ferreira","year":"2015","unstructured":"Ferreira RC, Simons HZ, Thompson WS et al (2015) IL-21 production by CD4+ effector T cells and frequency of circulating follicular helper T cells are increased in type 1 diabetes patients. Diabetologia 58:781\u2013790","journal-title":"Diabetologia"},{"key":"8033_CR55","doi-asserted-by":"publisher","first-page":"274","DOI":"10.3109\/1547691X.2015.1089343","volume":"13","author":"G Ghalamfarsa","year":"2016","unstructured":"Ghalamfarsa G, Mahmoudi M, Mohammadnia-Afrouzi M et al (2016) IL-21 and IL-21 receptor in the immunopathogenesis of multiple sclerosis. J Immunotoxicol 13:274\u2013285","journal-title":"J Immunotoxicol"},{"key":"8033_CR56","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1365-2133.2012.10899.x","volume":"167","author":"Z He","year":"2012","unstructured":"He Z, Jin L, Liu ZF et al (2012) Elevated serum levels of interleukin 21 are associated with disease severity in patients with psoriasis. Br J Dermatol 167:191\u2013193","journal-title":"Br J Dermatol"},{"key":"8033_CR57","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.3389\/fimmu.2019.01865","volume":"10","author":"Y Shi","year":"2019","unstructured":"Shi Y, Chen Z, Zhao Z et al (2019) IL-21 induces an imbalance of Th17\/Treg cells in moderate-to-severe plaque psoriasis patients. Front Immunol 10:1865","journal-title":"Front Immunol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-08033-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-022-08033-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-08033-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T14:34:24Z","timestamp":1675175664000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-022-08033-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,9]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["8033"],"URL":"https:\/\/doi.org\/10.1007\/s11033-022-08033-5","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,9]]},"assertion":[{"value":"18 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethical Committee of Tabriz University of Medical Sciences (IR.TBZMED.REC.1399.294).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all applicants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All authors and institutions have confirmed this manuscript for publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"consent for publications"}}]}}